Fluorescent Filter-Trap Assay for Amyloid Fibril Formation Kinetics in Complex Solutions

ACS Chemical Neuroscience

Volumn 6, Issue 8, 2015, Pages 1436-1444

  Nasir, Irem ^a   Linse, Sara ^a   Cabaleiro Lago, Celia ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

aggregation; Alzheimers disease; Amyloid; filter trap; kinetics; site specific fluorophore labeling

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; FLUORESCENT DYE; HUMAN SERUM ALBUMIN; NANOPARTICLE; POLYSTYRENE; THIOFLAVINE; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; POLYSTYRENE DERIVATIVE; SERUM ALBUMIN; SOLUTION AND SOLUBILITY; THIAZOLE DERIVATIVE;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; BINDING ASSAY; CHEMICAL INTERACTION; CHEMICAL PARAMETERS; CHEMICAL REACTION KINETICS; CONCENTRATION PROCESS; CONTROLLED STUDY; FILTRATION; FLUORESCENCE ANALYSIS; FLUORESCENT FILTER TRAP ASSAY; IMMUNODETECTION; PRIORITY JOURNAL; PROTEIN BINDING; REACTION TIME; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; CHEMICAL ANALYSIS; CHEMISTRY; ESCHERICHIA COLI; HUMAN; KINETICS; PROCEDURES; PROTEIN MULTIMERIZATION; SOLUTION AND SOLUBILITY; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID; AMYLOID BETA-PEPTIDES; CHEMISTRY TECHNIQUES, ANALYTICAL; ESCHERICHIA COLI; FLUORESCENT DYES; HUMANS; KINETICS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PEPTIDE FRAGMENTS; POLYSTYRENES; PROTEIN MULTIMERIZATION; SERUM ALBUMIN; SOLUTIONS; THIAZOLES;

EID: 84939782105     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/acschemneuro.5b00104     Document Type: Article

References (51)

1. Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., and Jones, E. (2011) Alzheimers disease Lancet 377, 1019-1031
2. Chiti, F. and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 333-366
3. Finder, V. H. (2010) Alzheimers disease: A general introduction and pathomechanism J. Alzheimers Dis. 22, S5-S19
4. Naslund, J., Schierhorn, A., Hellman, U., Lannfelt, L., Roses, A. D., Tjernberg, L. O., Silberring, J., Gandy, S. E., Winblad, B., Greengard, P., Nordstedt, C., and Terenius, L. (1994) Relative abundance of alzheimer a-beta amyloid peptide variants in alzheimer-disease and normal aging Proc. Natl. Acad. Sci. U.S.A. 91, 8378-8382
5. Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., and Teplow, D. B. (1999) Amyloid beta-protein fibrillogenesis-structure and biological activity of protofibrillar intermediates J. Biol. Chem. 274, 25945-25952
6. Hardy, J. A. and Higgins, G. A. (1992) Alzheimers disease-the amyloid cascade hypothesis Science 256, 184-185
7. Bateman, D. A., McLaurin, J., and Chakrabartty, A. (2007) Requirement of aggregation propensity of alzheimer amyloid peptides for neuronal cell surface binding, BMC Neurosci. 8.
8. Cohen, S. I. A., Vendruscolo, M., Dobson, C. M., and Knowles, T. P. J. (2012) From macroscopic measurements to microscopic mechanisms of protein aggregation J. Mol. Biol. 421, 160-171
9. Assarsson, A., Hellstrand, E., Cabaleiro-Lago, C., and Linse, S. (2014) Charge dependent retardation of amyloid beta aggregation by hydrophilic proteins ACS Chem. Neurosci. 5, 266-274
10. Assarsson, A., Linse, S., and Cabaleiro-Lago, C. (2014) Effects of polyamino acids and polyelectrolytes on amyloid beta fibril formation Langmuir 30, 8812-8818
11. Cabaleiro-Lago, C., Lynch, I., Dawson, K. A., and Linse, S. (2010) Inhibition of iapp and iapp((20-29)) fibrillation by polymeric nanoparticles Langmuir 26, 3453-3461
12. Cabaleiro-Lago, C., Quinlan-Pluck, F., Lynch, I., Lindman, S., Minogue, A. M., Thulin, E., Walsh, D. M., Dawson, K. A., and Linse, S. (2008) Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles J. Am. Chem. Soc. 130, 15437-15443
13. Hard, T. and Lendel, C. (2012) Inhibition of amyloid formation J. Mol. Biol. 421, 441-465
14. Rozga, M., Kloniecki, M., Jablonowska, A., Dandlez, M., and Bal, W. (2007) The binding constant for amyloid a beta 40 peptide interaction with human serum albumin Biochem. Biophys. Res. Commun. 364, 714-718
15. Shammas, S. L., Waudby, C. A., Wang, S., Buell, A. K., Knowles, T. P. J., Ecroyd, H., Welland, M. E., Carver, J. A., Dobson, C. M., and Meehan, S. (2011) Binding of the molecular chaperone alpha b-Crystallin to a beta amyloid fibrils inhibits fibril elongation Biophys. J. 101, 1681-1689
16. Hughes, E., Burke, R. M., and Doig, A. J. (2000) Inhibition of toxicity in the beta-amyloid peptide fragment beta-(25-35) using n-methylated derivatives-a general strategy to prevent amyloid formation J. Biol. Chem. 275, 25109-25115
17. LeVine, H. (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin t Methods Enzymol. 309, 274-284
18. Bruggink, K. A., Mueller, M., Kuiperij, H. B., and Verbeek, M. M. (2012) Methods for analysis of amyloid-beta aggregates J. Alzheimers Dis. 28, 735-758
19. Hellstrand, E., Boland, B., Walsh, D. M., and Linse, S. (2010) Amyloid beta-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process ACS Chem. Neurosci. 1, 13-18
20. Noormai, A., Primar, K., Tougu, V., and Palumaa, P. (2012) Interference of low-molecular substances with the thioflavin-t fluorescence assay of amyloid fibrils J. Pept. Sci. 18, 59-64
21. Necula, M., Kayed, R., Milton, S., and Glabe, C. G. (2007) Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct J. Biol. Chem. 282, 10311-10324
22. Jameson, L. P., Smith, N. W., and Dzyuba, S. V. (2012) Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (a beta) self-assembly ACS Chem. Neurosci. 3, 807-819
23. Winklhofer, K. F., Hartl, F. U., and Tatzelt, J. (2001) A sensitive filter retention assay for the detection of prpsc and the screening of anti-prion compounds FEBS Lett. 503, 41-45
24. Wanker, E. E., Scherzinger, E., Heiser, V., Sittler, A., Eickhoff, H., and Lehrach, H. (1999) Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates Methods Enzymol. 309, 375-386
25. Chang, E. and Kuret, J. (2008) Detection and quantification of tau aggregation using a membrane filter assay Anal. Biochem. 373, 330-336
26. Boye-Harnasch, M. and Cullin, C. (2006) A novel in vitro filter trap assay identifies tannic acid as an amyloid aggregation inducer for het-s J. Biotechnol. 125, 222-230
27. Jungbauer, L. M., Yu, C., Laxton, K. J., and LaDu, M. J. (2009) Preparation of fluorescently-labeled amyloid-beta peptide assemblies: The effect of fluorophore conjugation on structure and function J. Mol. Recognit. 22, 403-413
28. Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D., Delaglio, F., and Tycko, R. (2002) A structural model for alzheimers beta-amyloid fibrils based on experimental constraints from solid state nmr Proc. Natl. Acad. Sci. U.S.A. 99, 16742-16747
29. Cohen, S. I. A., Arosio, P., Presto, J., Kurudenkandy, F. R., Biverstal, H., Dolfe, L., Dunning, C., Yang, X., Frohm, B., Vendruscolo, M., Johansson, J., Dobson, C. M., Fisahn, A., Knowles, T. P. J., and Linse, S. (2015) A molecular chaperone breaks the catalytic cycle that generates toxic abeta oligomers Nat. Struct. Mol. Biol. 22, 207-213
30. Anderson, V. L. and Webb, W. W. (2011) Transmission electron microscopy characterization of fluorescently labelled amyloid beta 1-40 and alpha-synuclein aggregates, BMC Biotechnol. 11.
31. Cohen, S. I. A., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., and Knowles, T. P. J. (2013) Proliferation of amyloid-beta 42 aggregates occurs through a secondary nucleation mechanism Proc. Natl. Acad. Sci. U.S.A. 110, 9758-9763
32. He, X. M. and Carter, D. C. (1992) Atomic-structure and chemistry of human serum-albumin Nature 358, 209-215
33. Llewellyn, D. J., Langa, K. M., Friedland, R. P., and Lang, I. A. (2010) Serum albumin concentration and cognitive impairment Curr. Alzheimers Res. 7, 91-96
34. Kuo, Y. M., Emmerling, M. R., Lampert, H. C., Hempelman, S. R., Kokjohn, T. A., Woods, A. S., Cotter, R. J., and Roher, A. E. (1999) High levels of circulating a beta 42 are sequestered by plasma proteins in alzheimers disease Biochem. Biophys. Res. Commun. 257, 787-791
35. Sen, P., Fatima, S., Ahmad, B., and Khan, R. H. (2009) Interactions of thioflavin t with serum albumins: Spectroscopic analyses Spectrochim. Acta, Part A 74, 94-99
36. Taboada, P., Barbosa, S., Castro, E., and Mosquera, V. (2006) Amyloid fibril formation and other aggregate species formed by human serum albumin association J. Phys. Chem. B 110, 20733-20736
37. Milojevic, J., Raditsis, A., and Melacini, G. (2009) Human serum albumin inhibits a beta fibrillization through a "monomer-competitor" mechanism Biophys. J. 97, 2585-2594
38. Milojevic, J. and Melacini, G. (2011) Stoichiometry and affinity of the human serum albumin-alzheimers a beta peptide interactions Biophys. J. 100, 183-192
39. Milojevic, J., Esposito, V., Das, R., and Melacini, G. (2007) Understanding the molecular basis for the inhibition of the alzheimers a beta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation nmr spectroscopy J. Am. Chem. Soc. 129, 4282-4290
40. Stanyon, H. F. and Viles, J. H. (2012) Human serum albumin can regulate amyloid-beta peptide fiber growth in the brain interstitium implications for alzheimer disease J. Biol. Chem. 287, 28163-28168
41. Wu, W.-h., Sun, X., Yu, Y.-p., Hu, J., Zhao, L., Liu, Q., Zhao, Y.-f., and Li, Y.-m. (2008) Tio2 nanoparticles promote beta-amyloid fibrillation in vitro Biochem. Biophys. Res. Commun. 373, 315-318
42. Rocha, S., Thueneman, A. F., Pereira, M. d. C., Coelho, M., Moehwald, H., and Brezesinski, G. (2008) Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide Biophys. Chem. 137, 35-42
43. Araya, E., Olmedo, I., Bastus, N. G., Guerrero, S., Puntes, V. F., Giralt, E., and Kogan, M. J. (2008) Gold nanoparticles and microwave irradiation inhibit beta-amyloid amyloidogenesis Nanoscale Res. Lett. 3, 435-443
44. Yoo, S. I., Yang, M., Brender, J. R., Subramanian, V., Sun, K., Joo, N. E., Jeong, S.-H., Ramamoorthy, A., and Kotov, N. A. (2011) Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: Functional similarities with proteins Angew. Chem., Int. Ed. 50, 5110-5115
45. Liao, Y.-H., Chang, Y.-J., Yoshiike, Y., Chang, Y.-C., and Chen, Y.-R. (2012) Negatively charged gold nanoparticles inhibit alzheimers amyloid-beta fibrillization, induce fibril dissociation, and mitigate neurotoxicity Small 8, 3631-3639
46. Vacha, R., Linse, S., and Lund, M. (2014) Surface effects on aggregation kinetics of amyloidogenic peptides J. Am. Chem. Soc. 136, 11776-11782
47. Cabaleiro-Lago, C., Quinlan-Pluck, F., Lynch, I., Dawson, K. A., and Linse, S. (2010) Dual effect of amino modified polystyrene nanoparticles on amyloid beta protein fibrillation ACS Chem. Neurosci. 1, 279-287
48. Cukalevski, R., Boland, B., Frohm, B., Thulin, E., Walsh, D., and Linse, S. (2012) Role of aromatic side chains in amyloid beta-protein aggregation ACS Chem. Neurosci. 3, 1008-1016
49. Pace, C. N., Vajdos, F., Fee, L., Grimsley, G., and Gray, T. (1995) How to measure and predict the molar absorption-coefficient of a protein Protein Sci. 4, 2411-2423
50. Walsh, D. M., Thulin, E., Minogue, A. M., Gustavsson, N., Pang, E., Teplow, D. B., and Linse, S. (2009) A facile method for expression and purification of the alzheimers disease-associated amyloid beta-peptide FEBS J. 276, 1266-1281
51. Rusinova, E., Tretyachenko-Ladokhina, V., Vele, O. E., Senear, D. F., and Ross, J. B. A. (2002) Alexa and oregon green dyes as fluorescence anisotropy probes for measuring protein-protein and protein-nucleic acid interactions Anal. Biochem. 308, 18-25